Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 20, Issue 1
ABT-450/r-ombitasvir and dasabuvir with ribavirin eliminates viraemia in most patients with HCV infection with cirrhosis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Therapeutics/Prevention
Randomised controlled trial
ABT-450/r-ombitasvir and dasabuvir with ribavirin eliminates viraemia in most patients with HCV infection with cirrhosis
Free
Online download statistics by month:
Online download statistics by month: September 2014 to February 2024
Abstract
Full
Pdf
Sep 2014
95
6
13
Oct 2014
93
1
7
Nov 2014
41
3
3
Dec 2014
24
0
5
Jan 2015
169
10
13
Feb 2015
153
11
21
Mar 2015
122
12
22
Apr 2015
39
2
5
May 2015
41
3
4
Jun 2015
38
2
3
Jul 2015
44
6
3
Aug 2015
35
1
2
Sep 2015
21
3
1
Oct 2015
19
0
0
Nov 2015
23
3
2
Dec 2015
46
3
6
Jan 2016
42
7
5
Feb 2016
54
21
13
Mar 2016
14
10
21
Apr 2016
19
10
17
May 2016
34
19
14
Jun 2016
29
15
11
Jul 2016
24
12
5
Aug 2016
18
8
4
Sep 2016
22
9
4
Oct 2016
19
10
4
Nov 2016
13
7
2
Dec 2016
23
13
2
Jan 2017
24
4
3
Feb 2017
3
6
5
Mar 2017
1
9
5
Apr 2017
3
23
4
May 2017
2
70
15
Jun 2017
5
10
2
Jul 2017
13
11
6
Aug 2017
19
19
3
Sep 2017
31
23
0
Oct 2017
25
16
0
Nov 2017
29
12
5
Dec 2017
22
16
1
Jan 2018
27
17
3
Feb 2018
16
10
2
Mar 2018
15
15
0
Apr 2018
15
12
6
May 2018
17
17
4
Jun 2018
19
16
4
Jul 2018
21
20
1
Aug 2018
17
15
2
Sep 2018
7
7
0
Oct 2018
13
8
2
Nov 2018
18
10
1
Dec 2018
10
10
1
Jan 2019
17
11
2
Feb 2019
18
16
5
Mar 2019
4
3
4
Apr 2019
7
7
7
May 2019
8
4
3
Jun 2019
5
5
3
Jul 2019
14
10
6
Aug 2019
7
4
7
Sep 2019
4
4
1
Oct 2019
9
9
5
Nov 2019
4
3
2
Dec 2019
6
5
5
Jan 2020
17
8
4
Feb 2020
6
5
4
Mar 2020
2
2
4
Apr 2020
2
2
2
May 2020
8
8
2
Jun 2020
5
5
2
Jul 2020
8
8
2
Aug 2020
7
6
6
Sep 2020
8
8
1
Oct 2020
7
7
5
Nov 2020
8
5
3
Dec 2020
6
6
8
Jan 2021
10
7
2
Feb 2021
8
6
4
Mar 2021
8
8
5
Apr 2021
2
0
1
May 2021
2
2
3
Jun 2021
6
6
0
Jul 2021
7
7
2
Aug 2021
7
7
3
Sep 2021
10
9
3
Oct 2021
9
8
13
Nov 2021
6
4
9
Dec 2021
9
9
8
Jan 2022
13
11
2
Feb 2022
13
11
5
Mar 2022
17
15
3
Apr 2022
8
8
0
May 2022
24
21
8
Jun 2022
21
17
6
Jul 2022
17
15
0
Aug 2022
34
28
4
Sep 2022
36
25
12
Oct 2022
28
26
3
Nov 2022
11
11
4
Dec 2022
8
5
2
Jan 2023
10
7
4
Feb 2023
22
22
4
Mar 2023
3
3
1
Apr 2023
2
2
5
May 2023
8
6
4
Jun 2023
3
1
1
Jul 2023
12
4
5
Aug 2023
15
10
8
Sep 2023
2
2
2
Oct 2023
5
5
0
Nov 2023
21
12
10
Dec 2023
14
12
2
Jan 2024
27
26
1
Feb 2024
15
9
4
Total
2346
1121
533
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?